This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Value investing can be a powerful strategy for new investors. Learn key tips to enhance your investment skills and achieve better returns.
28,096 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
D-Wave Quantum’s stock sprinted higher this week, but a quick rally doesn’t equal a clear buy. This guide breaks down...
Rand Capital's Q1 2026 earnings set the tone for the year. This analysis breaks down the numbers, portfolio quality, ...
The telehealth scene has been volatile, and the hims hers health stock has seen sharp moves. This guide breaks down w...
Daré (DARE) has a developing pipeline and a tight cash runway. This article breaks down what the Q4 2025 earnings cal...
Railroads still power the economy, and the big players like Union Pacific and CSX remain compelling for long-term inv...
Gates Capital Management just raised its TIC Solutions position even as TIC’s stock fell this year. Learn what this m...
A prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
A leading U.S. health care powerhouse is quietly building an AI-driven engine that touches every corner of its busine...
A mid-2026 move by a hedge fund to exit EPAM Systems sparked questions about portfolio risk and disclosure. This guid...
Grail stock surged on hype around early cancer-detection tests, then faded after a mixed trial result. This article a...
A potential $67 billion move between nextera energy and duke energy could redefine how regulated utilities grow, fund...